These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 10746890)

  • 21. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society.
    North American Menopause Society
    Menopause; 2006; 13(6):862-77; quiz 878-80. PubMed ID: 17106282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation and management of the hormone replacement therapy (HRT) candidate.
    Hillard T
    Int J Fertil Womens Med; 1997; 42 Suppl 2():347-64. PubMed ID: 9397383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen use and postmenopausal women: a basis for informed decisions. NIH Consensus Development.
    Gastel B; Cornoni-Huntley J; Brody JA
    J Fam Pract; 1980 Nov; 11(6):851-60. PubMed ID: 7005387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimated gains in life expectancy with use of postmenopausal estrogen therapy: a decision analysis.
    Zubialde JP; Lawler F; Clemenson N
    J Fam Pract; 1993 Mar; 36(3):271-80. PubMed ID: 8454973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits of hormone replacement therapy--overview and update.
    Calaf i Alsina J
    Int J Fertil Womens Med; 1997; 42 Suppl 2():329-46. PubMed ID: 9397382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hormone replacement therapy of menopause, heart and blood vessels].
    Kuttenn F; Gerson M
    Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of isoflavones in menopausal health: consensus opinion of The North American Menopause Society.
    Menopause; 2000; 7(4):215-29. PubMed ID: 10914614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.
    Dubey RK; Imthurn B; Barton M; Jackson EK
    Cardiovasc Res; 2005 May; 66(2):295-306. PubMed ID: 15820198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study.
    McPherson R
    Can J Cardiol; 2000 Jan; 16 Suppl A():14A-9A. PubMed ID: 10653926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy and cardiovascular risk in post-menopausal women with NIDDM.
    Sattar N; Jaap AJ; MacCuish AC
    Diabet Med; 1996 Sep; 13(9):782-8. PubMed ID: 8891452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should women with diabetes mellitus receive hormone replacement therapy?
    Dunne FP
    Int J Clin Pract; 1997; 51(5):299-303. PubMed ID: 9489089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case in point. Counseling about hormone replacement therapy.
    Mahon SM
    Oncol Nurs Forum; 1998 May; 25(4):663-4. PubMed ID: 9599344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiovascular risk and hormone replacement therapy in menopause].
    Plu-Bureau G
    Therapie; 1999; 54(3):375-80. PubMed ID: 10500454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.